Skip to content
Search

Latest Stories

Pharmacy2U snaps up LloydsDirect, uniting UK's top online pharmacies

Pharmacy2U has recently acquired LloydsDirect in a confidential deal, bringing together two of the UK's foremost online pharmacies. Over time, both entities will integrate their operations under the Pharmacy2U brand, the companies said in a joint statement.

The two businesses complement each other effectively, and their teams will now work closely together to uphold the patient-centric approach and service quality for which both are known individually, the statement added. However, there is currently limited clarity regarding the sale process and its impact on Lloyds staff.


According to NHS Business Services Authority data from PharmData, Pharmacy2U dispensed 1,528,436 items in June 2023, while LloydsDirect, previously owned by LloydsPharmacy, dispensed 1,142,891 items. This positions them as the top two online prescription pharmacies for items dispensed, with Well.co.uk in third place at 128,691 items.

"We are delighted to welcome the LloydsDirect team to the Pharmacy2U family," said Kevin Heath, CEO of Pharmacy2U. "Their remarkable accomplishments over the past eight years, particularly in enhancing patient experience and prioritising sustainability, have been impressive. By blending the strengths of both our enterprises, we can offer patients enhanced access and convenience."

Heath emphasised that both companies offer dedicated leadership, a profound commitment to pharmacy, and an extended range of digital health offerings, complemented by cutting-edge dispensing technology. “We are enthusiastic about uniting two enterprises united by patient-centric values and online proficiency to advance the benefits of pharmacy for the NHS and its patients," he added.

“First and foremost, we believe this will benefit our patients and our efforts in supporting the NHS," added Connie Cha, Managing Director of LloydsDirect. "The achievements of both businesses highlight the dedication of the Pharmacy2U and LloydsDirect teams in providing accessible and convenient pharmacy services to assist patients in managing their prescriptions and overall health."

"We anticipate collaborating as a unified pharmacy team, utilising state-of-the-art technology and automation in dispensing, while also expanding access to digital services in the days ahead," Cha further said.

Pharmacy2U has been investing in resources to advanced clinical care and automated dispensing technology, modernising access to NHS services and broadening its health e-commerce offerings, the statement said. Established in 1999, the company currently serves over 750,000 patients across England, and reported a pre-tax profit of £2.9 million from revenues of £165.1 million for the fiscal year ending in March 2022.

LloydsDirect, initially known as Echo, started in 2015. It was acquired by McKesson UK, then-owners of LloydsPharmacy, in 2019 and was rebranded to its current name in July 2021. In November 2021, the LloydsPharmacy group was bought for £477 million by private equity company the Aurelius Group. Under the new ownership, the company experienced substantial divestment of its assets.

Meanwhile, the NHS Business Services Authority (NHSBSA) recently confirmed a net decrease of 101 pharmacies in England for the year ending March 31, 2023, compared to the previous period. This comprises 371 closures and 270 new contracts. Additionally, data from the General Pharmaceutical Council projected a decrease of 43 registered pharmacies in England, Wales, and Scotland during the same period.

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less